Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial

The International Classification of Headache Disorders, 3rd edition (beta version)

Cephalalgia · 2013 · 8.2K citations · Full text

Medicine, Neurology, Psychiatry +14

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

Jonathan A C Sterne, Ian R. White, John B. Carlin et al. · BMJ · 2009 · 7.2K citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

The International Classification of Headache Disorders: 2nd edition

Jes Olesen, Peter J. Goadsby, Tim Steiner · The Lancet Neurology · 2003 · 5.1K citations

Medicine, Neurology, Psychiatry +13

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

Robert H. Dworkin, Dennis C. Turk, Kathleen W. Wyrwich et al. · Journal of Pain · 2007 · 3.4K citations

Medicine, Pharmacotherapy, Outcomes Research +12

An SCN9A channelopathy causes congenital inability to experience pain

James J. Cox, Frank Reimann, Adeline K. Nicholas et al. · Nature · 2006 · 1.6K citations · Full text

Life Sciences, Neurobiology, Neuroscience +11